Introduction
============

Chronic obstructive pulmonary disease (COPD) is presently the only endemic disease in Sweden where mortality is increasing, according to the statistics of the Swedish Heart-Lung Association in 2013. The World Health Organization predicts that it will become the third leading cause of mortality worldwide in 2020.[@b1-copd-12-331] An estimated 400,000--700,000 people in Sweden suffer from the disease, which is characterized by a progressive persistent airflow limitation.[@b2-copd-12-331] An exacerbation means a temporary worsening in the COPD symptoms. Each person diagnosed with COPD has roughly 1.8 exacerbations annually, which are treated in the Swedish health care system.[@b3-copd-12-331] Since an exacerbation inevitably leads to a worsening of lung function[@b4-copd-12-331] and an increased risk of mortality,[@b5-copd-12-331] decreasing the number of exacerbations is an important medical goal. The etiology of a COPD exacerbation is unclear in one-third of the cases.[@b4-copd-12-331]

Swallowing and breathing are two complex processes that require a closely coordinated interaction of shared anatomical structures and physiological function.[@b6-copd-12-331] A normal swallow usually occurs in the beginning or middle of an exhalation when the breathing is interrupted by a short apnea of approximately 1 second.[@b7-copd-12-331] Shaker et al[@b8-copd-12-331] showed that subjects with COPD have a disrupted coordination between breathing and swallowing; they more often start their swallow in the inspiratory phase than do normal age-matched subjects. Oropharyngeal dysphagia is associated with an increased risk of aspiration pneumonia.[@b9-copd-12-331]

Recent research focuses on the correlation between COPD and dysphagia and on the relationship between dysphagia and increased exacerbations[@b10-copd-12-331],[@b11-copd-12-331] because of the complex coordination of breathing and swallowing. Gross et al[@b10-copd-12-331] found several abnormal aspects of respiratory timing during swallowing in patients with stable COPD. These patients swallowed at points in their respiratory cycle that could promote prandial aspiration exacerbations. In their hospital-based case--control study, Terada et al[@b12-copd-12-331] reported that an abnormal swallow reflex was associated with more frequent exacerbations of COPD. Two recent studies suggest that the duration of the events of the pharyngeal phase of swallowing is longer in COPD patients than in healthy controls when assessed through videofluoroscopic examination.[@b13-copd-12-331],[@b14-copd-12-331] This substantiates earlier research that dysphagia may be underdiagnosed in the COPD population.[@b15-copd-12-331]--[@b17-copd-12-331] Furthermore, Langmore et al[@b18-copd-12-331] showed that COPD was the strongest independent comorbidity predictor (odds ratio =2.49) for aspiration pneumonia in nursing home patients.

Cvejic et al[@b19-copd-12-331] provide one of the most convincing evidences to date of aspiration during swallowing in patients with stable and moderate COPD. They followed 16 patients with COPD in a case--control study using videofluoroscopy while monitoring respiration. Hospitalization and mortality were assessed at 36 months. Patients with COPD were more likely to have either penetration of pharyngeal contents into the larynx or actual aspiration when swallowing large fluid volumes (100 mL). Both of these were associated with tachypnea, reduced hyoid elevation, post-swallow pharyngeal residue, and a trend toward an adverse outcome.

The aim of our study was threefold: to examine the prevalence of swallowing dysfunction in a Swedish cohort of COPD patients with moderate to very severe airflow limitation, ie, Stages 2--4 according to the classification of the Global Initiative for Chronic Obstructive Lung Disease (GOLD);[@b2-copd-12-331]to analyze at what stage of the disease the patient started to experience problems with swallowing function; andto investigate gender differences in the number of dysphagia symptoms, ie, dysphagia burden.

Materials and methods
=====================

Participants
------------

Patients were recruited consecutively between May 2011 and March 2012 while being at their scheduled appointment with either the COPD nurse or pulmonologist. All recruited patients had a spirometry-verified COPD diagnosis, a post-bronchodilator ratio of the forced expiratory volume in 1 second (FEV~1~)/forced vital capacity (FVC) \<0.7 of predicted, and were in a stable phase of the disease, defined as no exacerbations for at least 3 months before being included in the study. Patients with a previous history of head/neck cancer, stroke, lung cancer, dementia, and neuromuscular disease were excluded. The 51 recruits were 21 males (41.2%) and 30 females (58.8%). Thirteen patients (26%) had moderate COPD (GOLD, Grade 2), 17 (33%) had severe COPD (Grade 3), and 21 (41%) were in a very severe stage of the disease (Grade 4). The study population characteristics are presented in [Table 1](#t1-copd-12-331){ref-type="table"}. Only patients taking their full nutrition (liquid and solid) by mouth were enrolled in the study. The study protocol, questionnaires and informed consent were approved by the Regional Ethical Review Board, Uppsala University, Uppsala, Sweden (Dnr2014/405).

Procedure
---------

After obtaining written informed consent, data were collected in a clinical environment by one speech-language pathologist (SLP). Spirometries were performed by the COPD nurses.

The following investigations were included: Spirometry testTwo-part questionnaireSwallowing tests

Pulmonary function
------------------

Predicted normal values of the spirometry depend on gender, age, height, mass, and ethnicity and are expressed in percentage. With the GOLD standard, we classified the airflow limitation in COPD patients as moderate when post-bronchodilator FEV~1~ was between 50% and 80% of the predicted value, severe between 30% and 50%, and very severe below 30% (or below 50% with defined negative prognostic factors). Our aim was to include patients with mild COPD (FEV~1~ ≥80% predicted), but this patient group is not generally found in specialized pulmonary clinics since their symptoms are discreet and easily interpreted, e.g. a common cold.

Spirometry and disease severity in COPD
---------------------------------------

Spirometry was performed with a dry volume spirometer (Welch Allyn, Skaneateles Falls, NY, USA; Spiro Perfect module) according to the Swedish COPD guidelines. A post-bronchodilator ratio of FEV~1~/best of FVC and vital capacity (VC) \<0.7 was used to define COPD. Swedish reference values[@b20-copd-12-331] were applied for the FEV~1~. The severity grading for the airway limitation was based on the highest FEV~1~ and expressed as a percentage of the predicted value as defined by GOLD.[@b2-copd-12-331]

Questionnaire
=============

The questionnaire designed for the study consisted of questions routinely used by SLPs to identify dysphagia symptoms and risk factors during clinical evaluation ([Table 2](#t2-copd-12-331){ref-type="table"}). At the time, there was no validated dysphagia questionnaire available in Sweden. Subjects were only asked to give a yes or no response since the aim was to look at prevalence and not the degree of possible swallowing dysfunction. Question 8 about serving size is a very subjective measurement. To reduce the subjectivity of the answers, participants were asked about the number of potatoes and meatballs they would normally serve themselves. After discussions with two of the hospital's dietitians, we defined the lower limit to one potato and six meatballs. Anything less than that was considered a small serving. Questions 1, 2, and 7 were selected for correlation with lung function. These three symptoms are some of the strongest clinical signs for identifying oropharyngeal dysphagia.[@b21-copd-12-331]

Swallowing tests
----------------

### Water swallow test

There is no validated dysphagia screening for COPD patients, so a timed test of swallowing capacity was used. This swallowing capacity test has a high intra- and interrater and test--retest reliability, with a sensitivity of 96% in neurogenic dysphagia.[@b22-copd-12-331] It does not discriminate between sensory and motor dysfunction, and it only measures swallowing capacity for liquids. The patient is asked to swallow 150 mL cold water as quickly as possible. Time is measured from the "go" signal to the last swallow, as recognized by return of the larynx to the rest position (seen exteriorly by the movement of the thyroid cartilage). Any coughing during or after the test and any changes in the quality of the voice after the test is noted. A swallowing capacity index of 10 mL/sec is regarded to be the lower normal level. After performing the water swallow test, subjects were categorized into two groups: those with a swallowing capacity that is considered to be within normal limits (≤15 seconds) and those who performed the test \>15 seconds.

### Cookie swallow test

Patients were asked to eat a dry cookie at their own pace and report any perception of retention in the mouth, pharynx, or esophagus. Any coughing or self-reported retention was scored as a "fail". All patients completed both swallowing tests.

Statistical analysis
--------------------

Descriptive and comparative statistical calculations were made through SPSS statistics, version 21 (IBM, Armonk, NY, USA), and in Microsoft Excel 97-2003, Windows version 20 (Microsoft Corporation, Redmond, WA, USA). Microsoft Excel 97-2003 was also used for graphic presentation. Demographic data are reported as means, standard deviation, and range. The Mann--Whitney U test was used to test the difference in lung function between the group that performed the swallowing capacity test in \>15 seconds and the group ≤15 seconds (normal). This test was used because the data were unevenly distributed and the groups were small.

Spearman's rank correlation coefficient was used to examine the correlation between lung function (FEV~1~%) and: Patients' subjective experience of suboptimal swallowing function manifested by coughing, choking, or bolus retention.Objectively assessed dysphagia (swallowing capacity test and cookie test).Both subjective and objective symptoms taken together.

The Mann--Whitney U test was also used to analyze whether the total number of dysphagia symptoms differed for men and women.

Results
=======

The following variables are included in the analysis: Subjective symptoms: questionnaireTest of liquid swallowing capacity (volume/sec): normal index =10 mL/secTest of solid bolus (cookie): coughing, choking, and/or bolus retention on solid bolus (oral, pharyngeal, and esophageal)Lung function (spirometry): FEV~1~% predicted, FEV~1~/VC.

Prevalence of self-reported swallowing dysfunction
--------------------------------------------------

Thirty-three of the 51 participants (65%) gave a positive answer to all or some of Questions 1, 2, and 7 in the questionnaire ([Table 2](#t2-copd-12-331){ref-type="table"}). Each of these questions had a positive response rate of approximately 36%. Twelve percent of the patients experienced all three of the symptoms. We chose to use these three questions for correlation with lung function. A further analysis showed that it was not altogether the same patients who experienced problems with choking, coughing, and bolus retention.

Swallowing tests -- objective symptoms
--------------------------------------

In this group of patients (n=51), 49% (n=25) showed signs or symptoms of swallowing dysfunction in either the cookie swallow test or the water swallow test, or both. Data extracted from the 150 mL water swallow test showed a subnormal swallowing speed in 35.3% of the patients ([Figure 1](#f1-copd-12-331){ref-type="fig"}). A clear tendency but no significant difference (*P*=0.068) was found in lung function for the groups who performed the swallowing capacity test within normal limits (≤15 seconds) and in \>15 seconds. Fifteen of the participants (29%) experienced problems with the cookie, either coughing or reported bolus retention.

Subjective and objective symptoms taken together
------------------------------------------------

[Table 3](#t3-copd-12-331){ref-type="table"} shows the distribution of number of dysphagia symptoms -- three subjective and two objective symptoms -- in relation to lung function. There was a symptom prevalence of 78% when subjective and objective symptoms were added up but not graded. This includes patients with one or more symptoms.

Statistically significant correlations
--------------------------------------

There were significant correlations found for lung function (FEV~1~) and the subjects' own experience of coughing, choking, and/or food getting stuck (ρ=−0.387, *P*=0.005), the subjects' objective swallowing dysfunction (ρ=−0.388, *P*=0.005), and combined dysphagia symptoms (ρ=−0.477, *P*\<0.001). [Figure 2](#f2-copd-12-331){ref-type="fig"} shows the significant negative correlation between lung function and the five dysphagia symptoms. A decrease in the *y*-axis (lung function) correlates with an increase in the *x*-axis (number of symptoms).

Gender difference in terms of number of dysphagia symptoms
----------------------------------------------------------

No significant difference was seen for male and female subjects regarding the number of dysphagia symptoms. The mean number of symptoms for men in this study was 2.05 (median =2) and for women 1.5 (median =1). The distribution between men and women within each group is illustrated in [Table 4](#t4-copd-12-331){ref-type="table"}.

Discussion
==========

This is, to our knowledge, the first study in Scandinavia to evaluate comprehensively the prevalence of swallowing dysfunction in patients with stable COPD. This study demonstrates that 78% of our patients with stable COPD were clinically at risk of dysphagia. This is significantly higher than the range 2.3%--16% in the general population recently reported by Kertscher et al.[@b23-copd-12-331]

The prevalence of dysphagia in COPD patients varies in previous studies, ranging from 17%[@b17-copd-12-331] to 85%.[@b15-copd-12-331] One reason for this is the inclusion criteria where the patients' lung functions vary significantly in the studies. All patients in Coelho's study[@b15-copd-12-331] were in Stage 4 of the disease and tracheotomized. Another factor affecting the reported prevalence is whether the patient reports a swallowing problem in a questionnaire or if this has been evaluated instrumentally. The high prevalence noted in our study may be explained by the fact that the majority of patients were in Stages 3 or 4 of the disease, the mean age of the cohort was 71 years (standard deviation 7.7), the self-reported symptoms and the results from the swallowing tests were analyzed together, and the patients were asked to give a yes or no answer in the questionnaire. No other alternatives were allowed. Swallowing is a complex activity, and some patients may be absolutely asymptomatic regarding their deglutition.[@b24-copd-12-331] We chose to analyze the signs or symptoms of swallowing dysfunction both subjectively as perceived by the patient and objectively through a screening test. We felt that one method alone would only explain one aspect of a multifaceted issue.

Our data showed a symptom range of 35%--78%. One reason for the discrepancy between subjective and objective symptoms could be simply that coughing is one of the most recognized signs of aspiration, and COPD patients are used to frequent coughing, as some of them pointed out. It might be difficult to distinguish a generic COPD cough from an aspiration cough, meaning that a chronic cough could potentially mask an aspiration. For these cases, we marked a "fail" in the cookie swallow test if a swallow was followed by a cough within 1 minute. For perceived bolus retention, data from Stein et al[@b16-copd-12-331] indicate that COPD patients have an increased risk of cricopharyngeal dysfunction, which often results in bolus retention in the sinus piriformis. In our study, 15 subjects (29%) coughed or reported bolus retention. We decided not to further differentiate between these two symptoms since the groups would have been very small and required an instrumental examination not possible for this study. Our aim was to examine prevalence, not to grade a possible dysphagia. Therefore, the high prevalence reported covers the whole spectrum from mild to severe dysphagia symptoms.

The symptom with the highest prevalence was xerostomia (70.6%), a condition that can cause dysphagia. We chose only to make a note of this but not to analyze it further. Xerostomia is a very common symptom in this patient group because almost all medication prescribed for COPD symptoms (eg, antibiotics, corticosteroids, diuretics, bronchodilators) can cause severe dry mouth: some patients choose to treat the condition and some do not.

We found a clear negative correlation between dysphagia burden expressed in number of dysphagia symptoms and lung function. The more signs and symptoms of a suboptimal swallowing, the worse the subject's lung function was ([Table 3](#t3-copd-12-331){ref-type="table"}). In the group of participants with the best lung function (Stage 2), six of them had no signs or symptoms of dysphagia at all. In contrast, all participants in Stage 4 with a lung function of FEV~1~ \<30% of predicted or FEV~1~ \<50% of predicted and defined negative prognostic factors had one or several signs or symptoms of a swallowing problem. However, one might also argue that approximately half of the participants with the best lung function and in a stable phase of the disease still experienced some problems with swallowing.

An issue to be considered is the mean age of the participants ([Table 1](#t1-copd-12-331){ref-type="table"}) since normal aging affects some parameters of swallowing and is considered to be an independent risk factor for a swallowing impairment.[@b25-copd-12-331] However, all our participants were ambulatory and lived at home and not in a nursing home.

In the past two decades, there has been a rapid increase in prevalence and mortality rates worldwide for COPD in women compared to men.[@b26-copd-12-331] Men and women also differ in the clinical symptoms. Men often report more sputum production, whereas health-related quality of life is lower for women than for men with COPD.[@b27-copd-12-331] However, in terms of swallowing capacity and dysphagia burden, we found no significant gender differences.

Conclusion
==========

Of 51 participants with stable COPD assessed with simple swallowing tests and a questionnaire, a significant number, over 2/3, demonstrated some swallowing difficulties. It is therefore recommended that COPD patients be asked if they experience any problems with swallowing while at their regular routine visit to the COPD nurse or pulmonary clinic.

We recognize that the water swallow and cookie swallow tests are screeners of dysphagia and not true diagnostic tests. The study would have been strengthened with the inclusion of an instrumental evaluation to better correlate biomechanical swallowing impairments and COPD, but this was unfortunately not an option. Although this might have inflated the prevalence of dysphagia due to false positives, our results show that some patients with COPD are prone to dysphagia while being in a stable phase of the disease. An unrecognized decreased swallowing capacity or prandial aspiration may precipitate or be an aggravating factor in exacerbations in these cases.

Further research should aim toward establishing data for improving health care outcomes, developing guidelines, and commissioning services for these patients.

Presented in part at the European Society for Swallowing Disorders Annual Meeting, Malmö, Sweden 2013.
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![Histogram showing over swallowing capacity where the lower normal reference value for 150 mL of water is 10 mL/sec (≤15 seconds).\
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![Scatterplot where the *y*-axis shows lung function expressed in FEV~1~%, and the *x*-axis shows number of dysphagia symptom(s): subjective and objective symptoms.\
**Abbreviation:** FEV~1~, forced expiratory volume in 1 second.](copd-12-331Fig2){#f2-copd-12-331}

###### 

Patient characteristics

  Variable                      Mean    SD     Range
  ----------------------------- ------- ------ --------------
  Age, years                    71      7.7    52--84
  BMI, kg/m^2^                  24      5.9    15--40
  FEV~1~, L                     1.02    0.6    0.37--3.49
  FEV~1~ %                      42.51   13.7   22.38--52.56
  Swallowing capacity, mL/sec   15.36   11.9   3.16--52.56

**Abbreviations:** BMI, body mass index; FEV~1~, forced expiratory volume in 1 second.

###### 

Result from the questionnaire

  Questionnaire                               N    \%     95% CI
  ------------------------------------------- ---- ------ ------------
  1\. Coughing during meals                   18   35.7   22.4--49.9
  2\. Choking                                 19   37.3   24.1--51.9
  3\. Dyspnea during meals                    11   21.6   11.2--35.3
  4\. Xerostomia                              36   70.6   56.2--82.5
  5\. Long meal duration                      25   49.0   34.7--63.4
  6\. Eats everything on the plate            33   64.7   50.1--77.6
  7\. Bolus retention; mouth and/or pharynx   18   35.3   22.4--49.9
  8\. Small servings                          23   45.1   40.3--68.9
  9\. Diminished appetite                     23   45.1   40.3--68.9

**Note:** Number of patients with subjective symptoms described in percent with a 95% CI.

**Abbreviation:** CI, confidence interval.

###### 

Results from the questionnaire and swallowing tests expressed in number of symptoms according to lung function

  Lung function (GOLD)   Number (%)   0 (%)     1         2         3        4       5
  ---------------------- ------------ --------- --------- --------- -------- ------- -------
  Stage 2                13 (26)      6         3         2         1        1       0
  Stage 3                17 (33)      5         7         2         2        1       0
  Stage 4                21 (41)      0         4         8         5        2       2
  Total                  51           11 (22)   14 (28)   12 (24)   8 (16)   4 (8)   2 (4)

**Abbreviation:** GOLD, Global Initiative for Chronic Obstructive Lung Disease.

###### 

Number of participants according to GOLD stage based on lung function (FEV~1~%) and gender ratio

  GOLD      FEV~1~% of predicted   N (%)      Male/female
  --------- ---------------------- ---------- -------------
  Stage 2   ≥50% to ≤−80%          13 (26)    7/6
  Stage 3   ≥30% to \<50%          17 (33)    6/11
  Stage 4   \<30%                  21 (41)    8/13
  Total                            51 (100)   21/30

**Abbreviations:** GOLD, Global Initiative for Chronic Obstructive Lung Disease; FEV~1~, forced expiratory volume in 1 second.
